![Quiver Logo](/static/img/logo-icon.png)
![GNFT logo](https://quiver-logos.s3.us-east-2.amazonaws.com/gnft.png)
GENFIT S.A. American Depositary Shares
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view GNFT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of GNFT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by GNFT's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to GNFT
Recent picks made for GNFT stock on CNBC
ETFs with the largest estimated holdings in GNFT
Flights by private jets registered to GNFT
![Quiver Logo](/static/img/logo-icon.png)